Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Katina Massad"'
Autor:
Jamie M. Jacobs, Kathryn Post, Katina Massad, Nora K. Horick, Emily A. Walsh, Julia Cohn, Chelsea S. Rapoport, Amy J. Clara, Michael H. Antoni, Steven A. Safren, Ann H. Partridge, Jeffrey M. Peppercorn, Elyse R. Park, Jennifer S. Temel, Joseph A. Greer
Publikováno v:
Cancer. 128:3541-3551
Patients taking adjuvant endocrine therapy (AET) after breast cancer face adherence challenges and symptom-related distress. We conducted a randomized trial to evaluate the feasibility, acceptability, and preliminary efficacy of a telehealth interven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b608f92108bea5fd35421b5108afcd
https://doi.org/10.1002/cncr.34409
https://doi.org/10.1002/cncr.34409
Autor:
Katherine C. Fuh, David G. Mutch, Matthew A. Powell, Premal H. Thaker, Carolyn K. McCourt, Andrea R. Hagemann, Ian S. Hagemann, Hollie Beck-Noia, Peinan Zhao, Lei Guo, Katina Massad, Gregory Opara, Marguerite L. Palisoul, Molly M. Greenwade, Jeanne M. Quinn
Supplementary Tables. S1 - AXL expression and chemoresponse. AXL h-score is significantly higher in chemoresistant tumors. S2 - MVA to predict chemoresistance. High AXL staining is associated with chemoresistance. S3 - Clinical and Pathological Chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a0fbf4f42a0a02bc43bca04d73f952
https://doi.org/10.1158/1535-7163.22510657
https://doi.org/10.1158/1535-7163.22510657
Autor:
Katherine C. Fuh, David G. Mutch, Matthew A. Powell, Premal H. Thaker, Carolyn K. McCourt, Andrea R. Hagemann, Ian S. Hagemann, Hollie Beck-Noia, Peinan Zhao, Lei Guo, Katina Massad, Gregory Opara, Marguerite L. Palisoul, Molly M. Greenwade, Jeanne M. Quinn
Ovarian cancer, one of the deadliest malignancies in female cancer patients, is characterized by recurrence and poor response to cytotoxic chemotherapies. Fewer than 30% of patients with resistant disease will respond to additional chemotherapy treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9d2b2d5b3d3f91750d21e4d665d260
https://doi.org/10.1158/1535-7163.c.6539674
https://doi.org/10.1158/1535-7163.c.6539674
Autor:
Katherine C. Fuh, David G. Mutch, Matthew A. Powell, Premal H. Thaker, Carolyn K. McCourt, Andrea R. Hagemann, Ian S. Hagemann, Hollie Beck-Noia, Peinan Zhao, Lei Guo, Katina Massad, Gregory Opara, Marguerite L. Palisoul, Molly M. Greenwade, Jeanne M. Quinn
Supplementary Figures. S1 - AXL and overall survival. High AXL is associated with poor OS. S2 - BGB324 treatment and downstream inhibition. BGB324 treatment inhibits pAXL and downstream activation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed34bdfcf7ac2bdb8206d9c00df92c3
https://doi.org/10.1158/1535-7163.22510660
https://doi.org/10.1158/1535-7163.22510660
Autor:
Katherine Fuh, Hollie Beck-Noia, David G. Mutch, M. Palisoul, Lei Guo, J.M. Quinn, Andrea R. Hagemann, Premal H. Thaker, Peinan Zhao, M. Greenwade, Carolyn K. McCourt, Gregory Opara, Matthew A. Powell, Katina Massad, Ian S. Hagemann
Publikováno v:
Molecular Cancer Therapeutics. 18:389-398
Ovarian cancer, one of the deadliest malignancies in female cancer patients, is characterized by recurrence and poor response to cytotoxic chemotherapies. Fewer than 30% of patients with resistant disease will respond to additional chemotherapy treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d0c02ac35a654e2e3b3a3645b6b1d9
https://doi.org/10.1158/1535-7163.mct-18-0537
https://doi.org/10.1158/1535-7163.mct-18-0537
Publikováno v:
Journal of Clinical Oncology. 39:181-181
181 Background: Patients with lung cancer who are treated with curative intent are rarely included in quality-of-life (QOL) intervention research in cancer, and the transition from treatment to surveillance is an understudied phase in lung cancer. Gi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7977e8b25f5772c5a3fc8762f5dd1489
https://doi.org/10.1200/jco.2020.39.28_suppl.181
https://doi.org/10.1200/jco.2020.39.28_suppl.181
Autor:
Daniel Wilke, Katina Massad, Whitney R. Grither, Katherine Fuh, Molly Greenwade, Greg Longmore, Holly Beck, Lei Guo
Publikováno v:
Clinical Cancer Research. 25:AP20-AP20
OBJECTIVES: Understand the role of stromal discoid domain receptor 2 (DDR2) expression in ovarian cancer metastasis METHODS: 111 high-grade serous ovarian cancer specimens were examined for stromal DDR2 protein expression by immunohistochemistry (IHC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d2808e50817b8a5482edf2bf5dc34a6
https://doi.org/10.1158/1557-3265.ovcasymp18-ap20
https://doi.org/10.1158/1557-3265.ovcasymp18-ap20